Keyron Medical Technology
PrivateLast Round
Accelerator
Sep 6, 2024
Est. Valuation
$375,000
Total Funding Raised
$610,000
Company Overview
Keyron Medical Technology operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in September 2024.
Keyron Medical Technology is a medical devices & equipment company developing ForePass®, a minimally-invasive, implantable alternative to gastric bypass surgery designed to reverse type-2 diabetes, NASH, and obesity.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keyron Medical Technology Comparables
Compare Keyron Medical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MetaModix | 91% | |
| Hangzhou Tongee Medical Technology Co., Ltd. | 85% | |
| BariaTek Medical | 85% |
For institutional investors. Book with your work email.
Keyron Medical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 6, 2024 | ||||
| Seed | Dec 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Keyron Medical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LIFTT EuroInvest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 6, 2024
$30K round led by Health Wildcatters
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 29, 2026
On Sep 29th '26, Keyron appoints former FDA Medical Device Center Director David Feigal as Board Chair, with responsibility for regulatory strategy as the ForePass platform advances toward first-in-human clinical development.
For institutional investors. Book with your work email.
Keyron Medical Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Keyron Medical Technology's valuation, stock price, and market status.
Is Keyron Medical Technology a public or private company?
Keyron Medical Technology is a private company.
What is the current stock price of Keyron Medical Technology?
Keyron Medical Technology is a private company, so its shares have no public market price. Caplight tracks Keyron Medical Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Keyron Medical Technology worth (valuation)?
Keyron Medical Technology's valuation is estimated at $375.0K based on funding round data.
Can I buy Keyron Medical Technology stock?
Keyron Medical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Keyron Medical Technology's last funding round?
Keyron Medical Technology's most recent funding round was Accelerator on September 6, 2024.
Who are the main investors in Keyron Medical Technology?
Key investors in Keyron Medical Technology include LIFTT EuroInvest.
Will Keyron Medical Technology IPO soon?
No public IPO plans have been announced for Keyron Medical Technology.
How can I track Keyron Medical Technology secondary market activity?
Caplight tracks bids, offers, and trades in Keyron Medical Technology's shares on secondary markets.